Tinlarebant is an oral therapy designed to reduce the accumulation of vitamin A based toxins that cause retinal disease.

MK-3000, formally known as EYE103, is an investigational, potentially first-in-class tetravalent, tri-specific antibody that acts as an agonist of the Wnt signaling pathway.

This patented technology is designed to enhance the light sensitivity of a multi-characteristic opsin developed by Nanoscope as a gene therapy.

AEYE Health is set to share the company’s FDA-cleared portable AI solution for autonomous diabetic retinopathy screening at several upcoming medical conferences in October. The device and the ...

In a study, a team of UCLA investigators detail a deep-learning model pre-trained on 2D scans that accurately predicts disease-risk factors from 3D medical-scan modalities. Toku’s AI technology, CLAiR ...

A recent paper reveals increasing rates of diabetic retinopathy in young patients with diabetes, sparking concerns over inadequate screening and management, especially among Black and Hispanic youths.

According to research conducted by investigators at the Perelman School of Medicine at the University of Pennsylvania School of Medicine, patients with a rare inherited disease affecting their sight ...

This patented technology is designed to enhance the light sensitivity of a multi-characteristic opsin developed by Nanoscope as a gene therapy. Nanoscope Therapeutics Inc. has acquired a license for ...

It is not every day that a paper about treating eye disease appears in The Lancet. 1 The article by Campochiaro et al1 on a clinical trial of gene therapy speaks to the potential impact of this ...

Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab At this year's EURETINA Congress, Timothy L Jackson PhD, MB ChB ...

Yousif Subhi, MD, PhD, delivered the Ophthalmologica Lecture, "Things That Matter: An Evidence-Based Approach to AMD and CSC." At this year's European Society of Retina Specialists (EURETINA), the ...

Applied Science, Inc. (ASI) is expanding its AdaptivMD chronic care workflow technology to Sierra Family Health Center (SFHC) and Western Sierra Medical Clinic (WSMC). ASI has integrated a retinal ...